CYP24A1 and prostate carcinoma: Gastro-intestinal (n = 9) and prostate cancer bone metastases had a tendency towards having a high CYP24A1 protein expression, whereas, in particular, breast cancer bone metastases had a rather low CYP24A1 protein expression (Figure 2B).